Donald N. Buell
- Infectious Diseases top 0.2%
- Antifungal resistance and susceptibility 36
- Epidemiology top 0.5%
- Fungal Infections and Studies 15
- Small Animals top 0.5%
- Infectious Diseases and Mycology 7
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 4
-
- Antibiotics Pharmacokinetics and Efficacy 8
-
- Glycosylation and Glycoproteins Research 5
-
- Pharmaceutical studies and practices 5
-
- Immune Cell Function and Interaction 5
- Co-authors
- Jesse RothJames R. GavinThomas J. WalshIhor BekerskyDavid M. NevillePierre De MeytsJames J. KeirnsJohn L. Fahey
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Donald N. Buell
71 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Infectious Diseases 3.7k
- Epidemiology 2.9k
- Small Animals 549
- Transplantation 178
- Applied Microbiology and Biotechnology 111
Countries citing papers authored by Donald N. Buell
This map shows the geographic impact of Donald N. Buell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald N. Buell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald N. Buell more than expected).
Fields of papers citing papers by Donald N. Buell
This network shows the impact of papers produced by Donald N. Buell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald N. Buell. The network helps show where Donald N. Buell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Donald N. Buell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 104 | |
| 2 | 2009 | 85 | |
| 3 | 2008 | 75 | |
| 4 | Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasisbreakdown → | 2007 | 478 |
| 5 | 2006 | 209 | |
| 6 | 2006 | 114 | |
| 7 | 2005 | 136 | |
| 8 | 2005 | 83 | |
| 9 | 2003 | 71 | |
| 10 | 2001 | 0 | |
| 11 | 2001 | 27 | |
| 12 | 1999 | 23 | |
| 13 | 1999 | 48 | |
| 14 | 1998 | 174 | |
| 15 | 1996 | 28 | |
| 16 | Role of staging in childhood non-Hodgkin's lymphoma. | 1977 | 11 |
| 17 | Erythroid differentiation in cultured Friend leukemia cells treated with metabolic inhibitors. | 1976 | 69 |
| 18 | 1975 | 50 | |
| 19 | 1973 | 22 | |
| 20 | 1965 | 7 |
About Donald N. Buell
Donald N. Buell is a scholar working on Infectious Diseases, Small Animals and Transplantation, having authored 73 papers that have together received 7.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (36 papers), Fungal Infections and Studies (15 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Infectious Diseases and Mycology (7 papers), Glycosylation and Glycoproteins Research (5 papers), Pharmaceutical studies and practices (5 papers), Immune Cell Function and Interaction (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Infectious Diseases (3.7k citations), Epidemiology (2.9k citations) and Small Animals (549 citations). Donald N. Buell has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Jesse Roth, James R. Gavin, Thomas J. Walsh, Ihor Bekersky, David M. Neville, Pierre De Meyts, James J. Keirns, John L. Fahey, Robert M. Fielding and Laura Kovanda. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.